Eurofins
US Supreme Court Declines to Hear CareDx Organ Transplant Patent Infringement Case
CareDx had petitioned the US Supreme Court to hear a patent infringement case brought against Natera and Eurofins Viracor.
MolDx Reimbursement Decision on Molecular Testing in Organ Transplants Causes Confusion, Concern
Premium
Transplant surgeons and patient advocates fear that the decision to reimburse only one test per patient visit will impede patient care and worsen healthcare disparities.
NIMA Partners, EmpowerDx Collaborate on Celiac Gene Test
The assay from EmpowerDx uses self-collected oral swabs to identify genetic risk for the autoimmune disease, and the companies offer results within 10 business days.
Appeals Court Rules in Favor of Eurofins Viracor in Patent Infringement Case With CareDx
The Federal Court of Appeals declared that CareDx's cell-free DNA analysis patent was invalid for the purpose of its claim against Eurofins.
Eurofins Scientific Acquires Vietnamese Genetic Testing Firm Gentis
Eurofins said the deal helps support its efforts to grow in Asia and in the advanced specialized clinical diagnostics space.
Jul 23, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Dec 15, 2020